藍盾股份(300297.SZ):控股股東被動減持60萬股 或存繼續被強平風險
格隆匯1月20日丨藍盾股份(300297.SZ)公佈,2022年1月20日,公司根據中國證券登記結算有限責任公司深圳分公司系統查詢結果獲悉,控股股東、實際控制人柯宗慶所持60萬股被解除質押凍結並於2022年1月19日賣出導致被動減持。
截至目前,柯宗慶所持公司股份全部處於司法凍結狀態。柯宗慶正在積極尋求解決方案並與相關各方加強溝通,但不排除在溝通過程中存在其所持公司股份繼續被強制平倉的風險;如其不能採取有效措施化解相關風險,有可能影響公司控制權的穩定,但不會對公司生產經營產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.